Hamid Rahmatullah Bin Abd Razak
Hamid Rahmatullah Bin Abd Razak
Department of Bioengineering, Imperial College London, London, UK
Sengkang General Hospital, Singapore
Joint first authors
Search for other papers by Hamid Rahmatullah Bin Abd Razak in
Google Scholar
PubMed
Sengkang General Hospital, Singapore
Joint first authors
Search for other papers by Hamid Rahmatullah Bin Abd Razak in
Google Scholar
PubMed
Daniel Chew
Daniel Chew
Faculty of Medicine, Imperial College London, London, UK
Joint first authors
Search for other papers by Daniel Chew in
Google Scholar
PubMed
Joint first authors
Search for other papers by Daniel Chew in
Google Scholar
PubMed
Zepur Kazezian
Zepur Kazezian
Department of Bioengineering, Imperial College London, London, UK
Search for other papers by Zepur Kazezian in
Google Scholar
PubMed
Search for other papers by Zepur Kazezian in
Google Scholar
PubMed
Anthony M.J. Bull
Anthony M.J. Bull
Department of Bioengineering, Imperial College London, London, UK
Search for other papers by Anthony M.J. Bull in
Google Scholar
PubMed
Search for other papers by Anthony M.J. Bull in
Google Scholar
PubMed
), such as autologous protein solution (APS) and autologous conditioned serum (ACS), have been fabricated as emerging therapies for knee OA. 10 In a systematic review by Ajrawat et al, it was concluded that AILBPs are a safe and tolerable injection
